1. Home
  2. STZ vs UTHR Comparison

STZ vs UTHR Comparison

Compare STZ & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Constellation Brands Inc.

STZ

Constellation Brands Inc.

HOLD

Current Price

$155.44

Market Cap

24.6B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$464.26

Market Cap

21.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STZ
UTHR
Founded
1945
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.6B
21.4B
IPO Year
1987
1999

Fundamental Metrics

Financial Performance
Metric
STZ
UTHR
Price
$155.44
$464.26
Analyst Decision
Buy
Buy
Analyst Count
17
12
Target Price
$168.65
$498.83
AVG Volume (30 Days)
3.0M
348.9K
Earning Date
01-07-2026
02-25-2026
Dividend Yield
2.64%
N/A
EPS Growth
66.89
16.08
EPS
6.27
26.38
Revenue
$9,383,000,000.00
$3,128,400,000.00
Revenue This Year
N/A
$13.57
Revenue Next Year
$0.34
$5.72
P/E Ratio
$24.69
$17.73
Revenue Growth
N/A
13.50
52 Week Low
$126.45
$266.98
52 Week High
$196.91
$519.99

Technical Indicators

Market Signals
Indicator
STZ
UTHR
Relative Strength Index (RSI) 55.53 38.73
Support Level $152.98 $464.16
Resistance Level $162.33 $479.41
Average True Range (ATR) 4.12 9.24
MACD -0.57 -1.25
Stochastic Oscillator 48.85 29.78

Price Performance

Historical Comparison
STZ
UTHR

About STZ Constellation Brands Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating 84% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands, effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 26% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: